Tweet Post to Your Wall.

Casper Testifies Before Subcommittee; Targets Asia-Pacific Soybean Regions

Paul Casper, a soybean farmer from Lake Preston, S.D., and president of the South Dakota Soybean Association, went before the Senate Finance Committee's Subcommittee on International Trade, Customs, and Global Competitiveness Wednesday. He highlight the importance of a strong and expanding relationship with trading partners in the Asia-Pacific region, and advocate for the aggressive pursuit of market-opening initiatives within the area.

Representing SDSA, and the American Soybean Association, Casper cited the staggering growth and potential of the Asia-Pacific region, which represents close to 60 percent of world GDP, nearly 50 percent of world trade, and is home to more than 2.7 billion people, as a major factor in expanded export opportunities for U.S. soybean producers. 

Casper hailed the recently-implemented free trade agreement between the U.S. and South Korea as evidence of how expanding trade with Asia-Pacific partners benefits American producers.

"Nearly two-thirds of U.S. agricultural exports to Korea are now duty-free, including U.S. soybeans for crushing and U.S. soybean meal," he stated. "Implementation of the agreement will also trigger the gradual elimination of tariffs on refined soybean oil over five years, and the elimination of tariffs on crude soybean oil over 10 years."

The potential inclusion of Japan in the Trans-Pacific Partnership free trade agreement was also a critical topic in Wednesday's testimony, as Casper reiterated the industry's support for Japan's entry into TPP, and encouraged the subcommittee to recognize the potential impact of the inclusion.

"Soybean farmers strongly support Japan joining the negotiations," Casper stated, pointing to increased export opportunities for U.S. dairy, pork, beef and poultry products, which require soybean meal as feed. 

Casper also called on the subcommittee to echo the industry's support for a pilot program to speed the process of approving new biotechnology traits in China.

 "China is the only major importing country that requires registration or deregulation of a biotech trait to be completed in an exporting country prior to even applying for import approval," he stated. "This requirement delays commercialization of new traits in the U.S. for as much as two years after U.S. regulatory approvals are obtained."